NASDAQ:CELZ

Creative Medical Technology (CELZ) Stock Forecast, Price & News

$4.92

-0.37 (-6.99%)

(As of 09/29/2023 ET)

Compare

Today's Range: $4.87
▼
$5.33
50-Day Range: $4.23
▼
$6.63
52-Week Range: $3.30
▼
$14.20

Volume: 44,348 shs
Average Volume: 70,520 shs
Market Capitalization: $6.94 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Creative Medical Technology MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Bearish
6.37% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.46
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($3.27) to ($3.21) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.16 out of 5 stars

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Creative Medical Technology.

2.0

Short Interest

Percentage of Shares Shorted
6.37% of the float of Creative Medical Technology has been sold short.
Short Interest Ratio / Days to Cover
Creative Medical Technology has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Creative Medical Technology has recently increased by 297.35%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Creative Medical Technology does not currently pay a dividend.
Dividend Growth
Creative Medical Technology does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CELZ.

2.5

News and Social Media Coverage

News Sentiment
Creative Medical Technology has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Creative Medical Technology this week, compared to 0 articles on an average week.
Search Interest
2 people have searched for CELZ on MarketBeat in the last 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Creative Medical Technology insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.80% of the stock of Creative Medical Technology is held by insiders.
Percentage Held by Institutions
Only 1.41% of the stock of Creative Medical Technology is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Creative Medical Technology are expected to grow in the coming year, from ($3.27) to ($3.21) per share.
Price to Book Value per Share Ratio
Creative Medical Technology has a P/B Ratio of 0.44. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Creative Medical Technology (NASDAQ:CELZ) Stock

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

CELZ Price History

30 days | 90 days | 365 days | Advanced Chart

CELZ Stock News Headlines

September 22, 2023 | finance.yahoo.com

What Makes Creative Medical Technology Holdings, Inc. (CELZ) a New Buy Stock

September 19, 2023 | finance.yahoo.com

Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain

October 1, 2023 | Goldco (Ad)

Biden's Digital Dollar Nightmare

On July 20th, 2023, the Federal Reserve launched FedNow, which could spark the fuse for a Digital Dollar. If a Digital Dollar happens, the government could: Monitor every transaction, keep track of your spending habits, and potentially control your individual choices… Which MAY steal your freedoms in one way or another. And if you don’t plan for this now... Your retirement savings could be at risk of being frozen, hacked, or deleted. You’ll want to act fast... Because with Biden’s long history of voting against Americans... Who knows how much longer until Biden strikes again! Get your hands on this FREE Wealth Protection Kit today and learn how you could shield your savings and investments before it’s too late!

August 24, 2023 | finance.yahoo.com

What Is Allogeneic Cell Therapy, And What’s Driving This Market’s 25%+ Annual Global Growth?

August 23, 2023 | benzinga.com

What Is Allogeneic Cell Therapy, And What's Driving This Market's 25%+ Annual Global Growth?

June 28, 2023 | msn.com

Creative Medical Technology regains Nasdaq listing compliance

June 12, 2023 | finance.yahoo.com

Creative Medical Technology Holdings Provides Corporate Update

June 12, 2023 | finance.yahoo.com

Creative Medical Technology Announces $2 Million Share Repurchase Program

October 1, 2023 | Behind the Markets (Ad)

Laser breakthrough could send stock soaring 2,467%

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

June 9, 2023 | msn.com

Creative Medical Technology Holdings announces reverse stock split to regain compliance

May 31, 2023 | finance.yahoo.com

Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy Platform

May 18, 2023 | msn.com

Creative Medical Releases Data From StemSpine Procedure For Chronic Lower Back Pain

May 18, 2023 | finance.yahoo.com

Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell Line

May 14, 2023 | finance.yahoo.com

Creative Medical Technology Holdings First Quarter 2023 Earnings: US$0.075 loss per share (vs US$0.18 loss in 1Q 2022)

April 13, 2023 | msn.com

Creative Medical (CELZ) Up 86% on Upbeat Diabetes Study Data

April 12, 2023 | msn.com

Creative Medical Technology Soars after Positive Drug Data

April 12, 2023 | benzinga.com

Thinking about buying stock in Newmark Group, Exscientia, Pardes Biosciences, Creative Medical Technology, or Somalogic?

April 12, 2023 | msn.com

Why Is Creative Medical Technology Stock Skyrocketing Today?

April 4, 2023 | finance.yahoo.com

Creative Medical Technology Holdings Announces Filing of 2022 Form 10-K and Provides Business Update

March 23, 2023 | msn.com

Creative Medical stock rises on seeking FDA orphan drug status for Brittle diabetes therapy

March 23, 2023 | finance.yahoo.com

Creative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 Diabetes

March 21, 2023 | finance.yahoo.com

Creative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform Development

March 7, 2023 | finance.yahoo.com

Creative Medical Technology Holdings Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201

February 14, 2023 | finance.yahoo.com

Three Year Follow-Up Results Confirm Efficacy of StemSpine® Procedure for Treating Chronic Lower Back Pain, with No Serious Adverse Effects

February 8, 2023 | benzinga.com

Thinking about buying stock in Creative Medical, Meta, Advanced Micro Devices, Carvana, or SeqLL?

February 8, 2023 | marketwatch.com

Creative Medical Technology Shares Double After Approval to Continue Clinical Trial

February 8, 2023 | msn.com

CELZ More Than Doubles on Greenlight for Diabetes Therapy Trial

See More Headlines

Receive CELZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creative Medical Technology and its competitors with MarketBeat's FREE daily newsletter.

CELZ Company Calendar

Last Earnings: 8/11/2023
Today: 10/01/2023
Next Earnings (Estimated): 11/10/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:CELZ
CUSIP: N/A
CIK: 1187953
Web: www.creativemedicaltechnology.com
Phone: (833) 336-7636
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-10,140,000.00
Net Margins: N/A
Pretax Margin: -12,637.84%
Return on Equity: -56.26%
Return on Assets: -52.68%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 34.42
Quick Ratio: 34.40

Sales & Book Value

Annual Sales: $90,000.00
Price / Sales: 77.08
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $11.27 per share
Price / Book: 0.44

Miscellaneous

Outstanding Shares: 1,410,000
Free Float: 1,369,000
Market Cap: $6.94 million
Optionable: Not Optionable
Beta: 2.60

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. Timothy Warbington (Age 61)
Co-Founder, Chairman, Pres & CEO
Comp: $429k

Mr. Donald Dickerson (Age 58)
Sr. VP, CFO & Director
Comp: $390k

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

CELZ Stock - Frequently Asked Questions

How have CELZ shares performed in 2023?: Creative Medical Technology's stock was trading at $3.8110 on January 1st, 2023. Since then, CELZ stock has increased by 29.1% and is now trading at $4.92.
View the best growth stocks for 2023 here.
Are investors shorting Creative Medical Technology?: Creative Medical Technology saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 89,800 shares, an increase of 297.3% from the August 31st total of 22,600 shares. Based on an average daily volume of 55,300 shares, the short-interest ratio is currently 1.6 days. Currently, 6.4% of the company's stock are sold short.
View Creative Medical Technology's Short Interest.
When is Creative Medical Technology's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, November 10th 2023.
View our CELZ earnings forecast.
How were Creative Medical Technology's earnings last quarter?: Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) posted its quarterly earnings data on Friday, August, 11th. The company reported ($0.78) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.83) by $0.05.

When did Creative Medical Technology's stock split?: Shares of Creative Medical Technology reverse split on Sunday, June 11th 2023. The 1-10 reverse split was announced on Sunday, June 11th 2023. The number of shares owned by shareholders was adjusted after the market closes on Sunday, June 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.
What is Creative Medical Technology's stock symbol?: Creative Medical Technology trades on the NASDAQ under the ticker symbol "CELZ."
How do I buy shares of Creative Medical Technology?: Shares of CELZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Creative Medical Technology's stock price today?: One share of CELZ stock can currently be purchased for approximately $4.92.
How much money does Creative Medical Technology make?: Creative Medical Technology (NASDAQ:CELZ) has a market capitalization of $6.94 million and generates $90,000.00 in revenue each year.
How can I contact Creative Medical Technology?: Creative Medical Technology's mailing address is 2017 W Peoria Ave, PHOENIX, AZ 85029-4916, United States. The official website for the company is www.creativemedicaltechnology.com. The company can be reached via phone at (833) 336-7636 or via email at kahl@equityny.com.

This page (NASDAQ:CELZ) was last updated on 10/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial